Polysaccharides from European Black Elderberry Extract Enhance Dendritic Cell Mediated T Cell Immune Responses.
Study Design
- Tipo de Estudo
- Other
- População
- None
- Intervenção
- Polysaccharides from European Black Elderberry Extract Enhance Dendritic Cell Mediated T Cell Immune Responses. None
- Comparador
- None
- Desfecho Primário
- None
- Direção do Efeito
- Mixed
- Risco de Viés
- Unclear
Abstract
European black elderberry (Sambucus nigra L.) is a popular way to treat common colds or influenza infections. Mechanistically, this might be due to a direct antiviral effect or a stimulatory effect on the immune system of the host. Here, we evaluated the modulatory effects of black elderberry derived water extract (EC15) and its polysaccharide enriched fractions (CPS, BOUND, and UNBOUND) in comparison to a conventional alcoholic extract (EE25), regarding the phenotypical and functional properties of dendritic cells (DCs), which are essential cells to induce potent T cell responses. Interestingly, the water extract and its polysaccharide fractions potently induced DC maturation, while the ethanol extract did not. Moreover, the capacity to stimulate T cells by these matured DCs, as assessed using MLR assays, was statistically higher when induced by the water extracted fractions, compared to immature DCs. On the other hand, the ethanol extract EE25 did not induce T cell stimulation. Finally, the cytokine expression profiles of these DC-T cell cocultures were assessed and correlated well with increased T cell stimulation. Also, the expression of inflammatory cytokines, such as IL-6, TNF-α, and IFN-γ was highly increased in the presence of the elderberry water extract EC15, and the polysaccharide enriched CPS, BOUND, and UNBOUND fractions, but not by EE25. Thus, from these data, we conclude that the polysaccharides present in water-derived elderberry fractions induce potent immune-modulatory effects, which represents the basis for a strong immune-mediated response to viruses including influenza.
Resumo Rápido
It is concluded that the polysaccharides present in water-derived elderberry fractions induce potent immune-modulatory effects, which represents the basis for a strong immune-mediated response to viruses including influenza.
Full Text
International Journal of
Article
Polysaccharides from European Black Elderberry Extract Enhance Dendritic Cell Mediated T Cell Immune Responses
- 1 Department of Immune Modulation, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, D-91052 Erlagen, Germany; [email protected]
- 2 Nutrition and Health Division, IPRONA AG/SPA, Industriestraße 1/6, 39011 Lana, Italy; [email protected]
- 3 Plant Biochemistry and Food Quality Group, Environmental and Biochemical Sciences Department, The James Hutton Institute, Invergowrie, Dundee DD2 5DA, UK; [email protected] (G.M.); [email protected] (C.A.)
* Correspondence: [email protected]
Citation: Stich, L.; Plattner, S.; McDougall, G.; Austin, C.; Steinkasserer, A. Polysaccharides from European Black Elderberry Extract Enhance Dendritic Cell Mediated T Cell Immune Responses. Int. J. Mol. Sci. 2022, 23, 3949. https://doi.org/10.3390/ ijms23073949
Academic Editor: Davide Barreca
Received: 28 February 2022 Accepted: 30 March 2022 Published: 1 April 2022
Copyright: © 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https:// creativecommons.org/licenses/by/ 4.0/).
Abstract: European black elderberry (Sambucus nigra L.) is a popular way to treat common colds or influenza infections. Mechanistically, this might be due to a direct antiviral effect or a stimulatory effect on the immune system of the host. Here, we evaluated the modulatory effects of black elderberry derived water extract (EC15) and its polysaccharide enriched fractions (CPS, BOUND, and UNBOUND) in comparison to a conventional alcoholic extract (EE25), regarding the phenotypical and functional properties of dendritic cells (DCs), which are essential cells to induce potent T cell responses. Interestingly, the water extract and its polysaccharide fractions potently induced DC maturation, while the ethanol extract did not. Moreover, the capacity to stimulate T cells by these matured DCs, as assessed using MLR assays, was statistically higher when induced by the water extracted fractions, compared to immature DCs. On the other hand, the ethanol extract EE25 did not induce T cell stimulation. Finally, the cytokine expression profiles of these DC—T cell cocultures were assessed and correlated well with increased T cell stimulation. Also, the expression of inflammatory cytokines, such as IL-6, TNF-α, and IFN-γ was highly increased in the presence of the elderberry water extract EC15, and the polysaccharide enriched CPS, BOUND, and UNBOUND fractions, but not by EE25. Thus, from these data, we conclude that the polysaccharides present in water-derived elderberry fractions induce potent immune-modulatory effects, which represents the basis for a strong immune-mediated response to viruses including influenza.
Keywords: European black elderberry; dendritic cells; T cell stimulation; polysaccharides
European black elderberries and extracts thereof have been reported to reduce cold and flu-associated symptoms during viral infections and to restrict the time of infections [1–3]. Several randomized, placebo-controlled clinical trials, have confirmed such effects during the last decades [4].
However, the precise underlying mode of action(s) is/are still unclear and both, direct antiviral activities, as well as immune-mediated mechanisms, could play an important role. Regarding the first hypothesis, several authors described a direct antiviral effect showing that the main anthocyanin present in black elderberry, that is, cyanidin-3-sambubiocide, can bind and inhibit the active pocket of the viral enzyme neuraminidase and therefore inhibit the viral replication process in vitro [5]. In addition, Roschek et al., reported that in vitro flavonoids present in elderberry fruits can directly bind to H1N1 influenza virus particles, thereby inhibiting host cell entry [6]. This direct antiviral activity of secondary plant components may be very important for the fast and short-term elimination of viral particles; however, for the induction of long-lasting antiviral responses, the immune
Int. J. Mol. Sci. 2022, 23, 3949. https://doi.org/10.3390/ijms23073949 https://www.mdpi.com/journal/ijms
system must be activated via its innate and adaptive constituents. Therefore, it is very intriguing to speculate that specific components present in elderberry extracts may be able to stimulate/modulate the immune system of the host. Supporting this hypothesis, it has been reported, that in addition to polyphenols, Sambucus nigra fruits also contain peptic polysaccharides that have been shown to influence the immune system via the activation of macrophages [7,8].
While many extracts at an industrial scale are manufactured using alcoholic extraction techniques followed by purification methods to enrich anthocyanins at high levels, it can be assumed that a great part of the polysaccharide fraction is lost during such a process. In this work, we compare the immunomodulatory ability of two different extracts; a water extract produced using ultrafiltration and a conventional ethanolic extract.
For the induction of specific anti-viral immune responses, DCs are absolutely vital since they have the potential to activate also naïve T cells [9]. DCs connect the innate with the adaptive immune system, and under steady-state conditions, immature DCs reside in peripheral tissues, waiting for the encounter with pathogens including viruses. After the activation via, for example, inflammatory signals, immature DCs (iDCs) change their phenotype and function and become mature DCs (mDCs) [10]. mDCs increase the antigen processing and presenting capabilities, which goes along with the increased expression of MHC class I and class II, costimulatory molecules such as CD80, CD86 and CD40 as well as CD83, which is an important immune check point molecule expressed by mDCs [11].
Considering, that DCs are crucial players in the induction of effective antiviral immune responses, and knowing that elderberry-derived substances have been reported to strengthen the protection against viral infections, we investigated if polysaccharide enriched elderberry extract fractions could modulate the phenotype and enhance the immune stimulatory function of DCs. To investigate the effects of elderberry extracts on the DC phenotype, we used FACS analyses. To assess the DC-specific T-cell-stimulatory capacity, the Mixed Leukocyte Reaction (MLR) assay was employed. Furthermore, the expression of inflammatory cytokines present in the cell-free supernatant of DC-T cell co-cultures was analyzed using the Cytokine Bead Assay. Thus, within this study, we investigated elderberry-induced effects with respect to the phenotypic expression of DC-specific cell surface molecules, the T cell stimulatory capacity of mDCs as well as the induced cytokine profile in DC-T cell co-cultures.
- 2.1. Anthocyanin Quantification
- 2.2. Polysaccharide Isolation
No polysaccharides could be detected in the ethanolic extract (EE25). Several different polysaccharides enriched fractions were isolated from black elderberry water extract EC15. The Crude Polysaccharide fraction (CPS) was isolated using a series of ethanolic prescriptions. These precipitates were further fractionated using anion exchange chromatography, resulting in a flow-through polysaccharide-rich fraction (UNBOUND) and a bound fraction (BOUND). Monosaccharide analysis (Figure 1) revealed that the BOUND fraction was enriched in galacturonic acid and lower amounts of galactose, arabinose, and rhamnose, which is a similar composition to that reported previously for pectins extracted from elderberry [7]. The BOUND sample had notably reduced amounts of glucose, galactose, xylose, and mannose compared to the CPS, which indicated the removal of neutral polysaccharides by the ion exchange procedure. The higher glucose and xylose content of the CPS may also reflect the presence of these sugars in anthocyanins [12] that remained in this fraction.
Figure 1. Monosaccharide composition of the crude polysaccharide fraction (CPS), the unbound fraction (UNBOUND), and the bound fraction (BOUND), following anion exchange purification. Percentages of total monosaccharide content are shown (±SE, n = 4 for CPS and 6 for unbound and bound). The BOUND fraction was enriched in galacturonic acid and contained galactose, arabinose, and rhamnose. The BOUND sample had reduced amounts of glucose, galactose, xylose, and mannose compared to the CPS, which indicated the removal of neutral polysaccharides by the ion exchange procedure.
Figure 1. Monosaccharide composition of the crude polysaccharide fraction (CPS), the unbound fraction (UNBOUND), and the bound fraction (BOUND), following anion exchange purification. Percentages of total monosaccharide content are shown (±SE, n = 4 for CPS and 6 for unbound and bound). The BOUND fraction was enriched in galacturonic acid and contained galactose, arabinose, and rhamnose. The BOUND sample had reduced amounts of glucose, galactose, xylose, and mannose compared to the CPS, which indicated the removal of neutral polysaccharides by the ion exchange procedure.
2.3. Impact of Elderberry Derived Fractions on the Immune Phenotype of Dendritic Cells
In order to become potent APCs capable to activate naive T cells, DCs have to mature. DC maturation can be induced by inflammatory cytokines, molecules present on pathogens, or other specific stimulatory factors.
2.3. Impact of Elderberry Derived Fractions on the Immune Phenotype of Dendritic Cells
To investigate if the elderberry fractions were able to induce DC maturation, we incubated immature DCs (iDCs) with the extracts EC15, and EE25 and the CPS, BOUND, and UNBOUND fractions and analyzed the expression of specific surface molecules, typically upregulated on mature DCs (mDCs). The expression of the surface molecule CD11c was significantly increased in EC15, CPS, BOUND and UNBOUND treated cells, compared to iDCs (Figure 2a). In sharp contrast, EE25 treated iDCs did not increase the expression of CD11c, suggesting that EE25 does not induce DC maturation (Figure 2a). Interestingly, also MHCII, CD80, CD86, as well as CD40 molecules were significantly upregulated by the treatment of iDCs with EC15, CPS, BOUND, and the UNBOUND fractions (Figure 2b–e). In addition, the important surface marker for mDCs, that is, CD83 was highly upregulated in elderberry treated iDCs (Figure 2f). In sharp contrast, EE25 treatment of iDC had no effect on the expression of these typical maturation markers and co-stimulatory molecules (Figure 2a–f). In summary, the elderberry fractions EC15, CPS, BOUND, and UNBOUND induced the phenotypic maturation of iDCs into mDCs, which is an absolute prerequisite to strongly induce antigen-specific T cells. In contrast, EE25 did not induce these phenotypical changes and therefore was unable to promote DC maturation (Figure 2a–f).
In order to become potent APCs capable to activate naϊve T cells, DCs have to mature. DC maturation can be induced by inflammatory cytokines, molecules present on pathogens, or other specific stimulatory factors.
To investigate if the elderberry fractions were able to induce DC maturation, we incubated immature DCs (iDCs) with the extracts EC15, and EE25 and the CPS, BOUND, and UNBOUND fractions and analyzed the expression of specific surface molecules, typically upregulated on mature DCs (mDCs). The expression of the surface molecule CD11c was significantly increased in EC15, CPS, BOUND and UNBOUND treated cells, compared to iDCs (Figure 2a). In sharp contrast, EE25 treated iDCs did not increase the expression of CD11c, suggesting that EE25 does not induce DC maturation (Figure 2a). Interestingly, also MHCII, CD80, CD86, as well as CD40 molecules were significantly upregulated by the treatment of iDCs with EC15, CPS, BOUND, and the UNBOUND fractions (Figure 2b–e). In addition, the important surface marker for mDCs, that is, CD83 was highly upregulated in elderberry treated iDCs (Figure 2f). In sharp contrast, EE25 treat-
not induce these phenotypical changes and therefore was unable to promote DC maturation (Figure 2a–f).
Int. J. Mol. Sci. 2022, 23, 3949 4 of 17
- 0
- 1
- 2
- 3
normalized to iDC
10µg/ml CPS 10µg/ml
10µg/ml
10µg/ml EE25 10µg/ml
C
- D
- E
iD
m
D
D
C15
N
N
U
U
O
- N
- O
B
U
(a)
MHCII
- 0
- 1
- 2
- 3
- 4
- 5
normalized to iDC
10µg/ml CPS 10µg/ml
10µg/ml
10µg/ml EE25 10µg/ml
C
- D
- E
iD
m
D
D
C15
N
N
U
U
O
- N
- O
B
U
Figure 2. Cont.
(b)
Int. J. Mol. Sci.Int. J. Mol. Sci.20222022, 23, 3949, 23, x FOR PEER REVIEW 5 of 175 of
6
normalized to iDC
4
2
0
10µg/ml CPS 10µg/ml
10µg/ml
10µg/ml EE25 10µg/ml
C
- D
- E
iD
m
D
D
C15
N
N
U
U
O
- N
- O
B
U
(c)
20
normalized to iDC
15
10
5
0
10µg/ml CPS 10µg/ml
10µg/ml
10µg/ml EE25 10µg/ml
C
- D
- E
iD
m
D
D
C15
N
N
U
U
O
- N
- O
B
U
Figure 2. Cont.
(d)
Int. J. Mol. Sci.Int. J. Mol. Sci.2022, 23, 39492022 6 of 17
CD40
8
normalized to iDC
6
4
2
0
10µg/ml CPS 10µg/ml
10µg/ml
10µg/ml EE25 10µg/ml
C
C
D
iD
m
D
D
C15
N
N
U
U
E
O
O
B
B
N
U
(e)
CD83
40
normalized to iDC
30
20
10
0
10µg/ml CPS 10µg/ml
10µg/ml
10µg/ml EE25 10µg/ml
C
- D
- E
iD
m
D
D
C15
N
N
U
U
O
- N
- O
B
U
Figure 2. Cont.
(f)
Int. J. Mol. Sci.Int. J. Mol. Sci.2022, 232022, 3949, 23 7 of 177
2.0
ns ns ns ns ns ns
normalized to iDC
1.5
1.0
0.5
0.0
10µg/ml CPS 10µg/ml
10µg/ml
10µg/ml EE25 10µg/ml
C
C
D
iD
m
D
D
C15
N
N
U
U
E
O
O
B
B
N
U
(g)
Figure 2. (a): Effect of elderberry derived fractions on expression of CD11c in treated iDCs compared to untreated iDCs, and mDCs. Phenotypic cell surface expression was analyzed via flow cytometry. Asterisks mark statistically significant difference (* p < 0.05 and ** < 0.01). ns: no statistical significance. (n = 7–18). (b): Effect of elderberry-derived fractions on expression of MHCII in treated iDCs compared to untreated iDCs, and mDCs. Asterisks mark statistically significant difference (**** 0.0001). ns: no statistical significance. (n = 7–18). (c): Effect of elderberry derived fractions on expression of CD80 in treated iDCs compared to untreated iDCs, and mDCs. Asterisks mark statistically significant difference (**** p < 0.0001). ns: no statistical significance. (n = 7–18). (d): Effect of elderberry derived fractions on expression of CD86 in treated iDCs compared to untreated iDCs, and mDCs. Asterisks mark statistically significant difference (**** p < 0.0001). ns: no statistical significance. (n = 7–18). (e): Effect of elderberry derived fractions on expression of CD40 in treated iDCs compared to untreated iDCs, and mDCs. Asterisks mark statistically significant difference (**** 0.0001). ns: no statistical significance. (n = 7–18). (f): Effect of elderberry-derived fractions on expression of CD83 in treated iDCs compared to untreated iDCs and mDCs. Asterisks mark statistically significant difference (*** p < 0.001 and **** p < 0.0001). ns: no statistical significance. (n = 7–18). ( Effect of elderberry-derived fractions on cell viability using 7-AAD cells. None of the elderberry extracts and fractions, that is, EC15, CPS, BOUND, UNBOUND, or EE25, induced significant levels of cell death when compared to untreated control iDCs. For dead cell discrimination, 7-AAD viability staining solution was directly added to the surface staining, prior to subsequent FACS analyses. ns: no statistical significance. (n = 7–18).Each dot represent an independent experiment.
Figure 2. (a): Effect of elderberry derived fractions on expression of CD11c in treated iDCs compared to untreated iDCs, and mDCs. Phenotypic cell surface expression was analyzed via flow cytometry. Asterisks mark statistically significant difference (* p < 0.05 and ** p < 0.01). ns: no statistical significance. (n = 7–18). (b): Effect of elderberry-derived fractions on expression of MHCII in treated iDCs compared to untreated iDCs, and mDCs. Asterisks mark statistically significant difference (**** p < 0.0001). ns: no statistical significance. (n = 7–18). (c): Effect of elderberry derived fractions on expression of CD80 in treated iDCs compared to untreated iDCs, and mDCs. Asterisks mark statistically significant difference (**** p < 0.0001). ns: no statistical significance. (n = 7–18). (d): Effect of elderberry derived fractions on expression of CD86 in treated iDCs compared to untreated iDCs, and mDCs. Asterisks mark statistically significant difference (**** p < 0.0001). ns: no statistical significance. (n = 7–18). (e): Effect of elderberry derived fractions on expression of CD40 in treated iDCs compared to untreated iDCs, and mDCs. Asterisks mark statistically significant difference (**** p < 0.0001). ns: no statistical significance. (n = 7–18). (f): Effect of elderberry-derived fractions on expression of CD83 in treated iDCs compared to untreated iDCs and mDCs. Asterisks mark statistically significant difference (*** p < 0.001 and **** p < 0.0001). ns: no statistical significance. (n = 7–18). (g): Effect of elderberry-derived fractions on cell viability using 7-AAD cells. None of the elderberry extracts and fractions, that is, EC15, CPS, BOUND, UNBOUND, or EE25, induced significant levels of cell death when compared to untreated control iDCs. For dead cell discrimination, 7-AAD viability staining solution was directly added to the surface staining, prior to subsequent FACS analyses. ns: no statistical significance. (n = 7–18). Each dot represent an independent experiment.
Finally, to exclude that the treatment of DCs with the different elderberry extracts had a toxic effect, we checked cell viability using 7-AAD, which was not affected by any of the used elderberry-derived fractions (Figure 2g).
Finally, to exclude that the treatment of DCs with the different elderberry extracts had a toxic effect, we checked cell viability using 7-AAD, which was not affected by any of the used elderberry-derived fractions (Figure 2g).
2.4. Impact of Elderberry Derived Substances on the T Cell Stimulatory Potential of Dendritic
2.4. Impact of Elderberry Derived Substances on the T Cell Stimulatory Potential of Dendritic Cells
Certain elderberry-derived substances induced the phenotypic maturation of DCs and thus we investigated whether this translated also into a better T cell stimulatory capacity. Thus, DC-mediated T cell activation was assessed in the presence of different elderberry fractions using the mixed lymphocyte reaction (MLR) assay, where co-cultured cells were pulsed with 3H-thymidine to determine their allogeneic T cell proliferation. As shown in Figure 3a–e, iDCs induced a weak T cell proliferative response. In contrast, EC15
Certain elderberry-derived substances induced the phenotypic maturation of DCs and thus we investigated whether this translated also into a better T cell stimulatory capacity. Thus, DC-mediated T cell activation was assessed in the presence of different elderberry fractions using the mixed lymphocyte reaction (MLR) assay, where co-cultured cells were pulsed with 3H-thymidine to determine their allogeneic T cell proliferation. As shown in
- Int. J. Mol. Sci. 2022, 23, x FOR PEER REVIEW 8 of 18
Figure 3a–e, iDCs induced a weak T cell proliferative response. In contrast, EC15 (Figure 3a) and the fractions CPS (Figure 3b), BOUND (Figure 3c), and UNBOUND (Figure 3d) induced a strong and statistically highly significant T-cell-specific immune response, when compared to untreated iDCs. Also, fraction EE25 did not induce a significantly increased T cell response, when compared to untreated iDCs. Thus, these data clearly show that fractions EC15, CPS, BOUND, and UNBOUND induce a highly increased DC-mediated T cell response when compared to untreated or EE25 treated iDCs.
(Figure 3a) and the fractions CPS (Figure 3b), BOUND (Figure 3c), and UNBOUND (Fig-
3d) induced a strong and statistically highly significant T-cell-specific immune response, when compared to untreated iDCs. Also, fraction EE25 did not induce a significantly increased T cell response, when compared to untreated iDCs. Thus, these data clearly show that fractions EC15, CPS, BOUND, and UNBOUND induce a highly increased DC-mediated T cell response when compared to untreated or EE25 treated iDCs.
20,000
*
****
15,000
***
cpm
10,000
5,000
0
1:1333
1:133
1:400
DC:Tcell ratio
(a)
iDC
EC15 10µg/ml
25,000
***
20,000
**** ****
15,000
cpm
10,000
5,000
0
1:1333
1:133
1:400
DC:Tcell ratio
Figure 3. Cont.
(b)
iDC
CPS 10µg/ml
- Int. J. Mol. Sci. 2022, 23, x FOR PEER REVIEW 9
Int. J. Mol. Sci. 2022, 23, 3949 9 of 17
25,000
20,000
15,000
cpm
10,000
5,000
0
1:1333
1:133
1:400
DC:Tcell ratio
(c)
iDC
BOUND 10µg/ml
25,000
****
20,000
****
****
15,000
cpm
10,000
5,000
0
1:1333
1:133
1:400
DC:Tcell ratio
Figure 3. Cont.
(d)
iDC
UNBOUND 10µg/ml
15,000
ns
ns
10,000
cpm
ns
5,000
0
1:1333
1:133
1:400
DC:Tcell ratio
iDC
EE25 10µg/ml
Figure 3. (a): MLR assays comparing untreated and EC15 treated iDCs. The effect of elderberry extract EC15 regarding the DC-mediated T cell stimulation was assessed using the mixed lymphocyte reaction (MLR) assay, in comparison to untreated iDCs. iDC were pre-treated with 10µg/mL EC15 for 24 h and co-cultured with allogeneic T-cells in the MLR assay. T-cell proliferation was measured upon 3H-thymidin incorporation. Asterisks mark statistically significant difference (* p < 0.05, *** < 0.001 and **** p < 0.0001). ns: no statistical significance. (n = 6). (b): MLR assays comparing untreated and CPS treated iDCs. Description as Figure 3a. Asterisks mark statistically significant difference (*** p < 0.001 and **** p < 0.0001). ns: no statistical significance. (n = 6). (c): MLR assays comparing untreated and BOUND treated iDCs. Description as Figure 3a. Asterisks mark statistically significant difference (**** p < 0.0001). ns: no statistical significance. (n = 3–6). (d): MLR assays comparing untreated and UNBOUND treated iDCs. Description as Figure 3a. Asterisks mark statistically significant difference **** p < 0.0001). ns: no statistical significance (n = 3–6). (e): MLR assays comparing untreated and EE25 treated iDCs. Description as Figure 3a. ns: no statistical significance. (n = 3–6).
- Figure 3. (a): MLR assays comparing untreated and EC15 treated iDCs. The effect of elderberry extract EC15 regarding the DC-mediated T cell stimulation was assessed using the mixed lymphocyte reaction (MLR) assay, in comparison to untreated iDCs. iDC were pre-treated with 10µg/mL EC15 for 24 h and co-cultured with allogeneic T-cells in the MLR assay. T-cell proliferation was measured upon 3H-thymidin incorporation. Asterisks mark statistically significant difference (* p < 0.05, *** p < 0.001 and **** p < 0.0001). ns: no statistical significance. (n = 6). (b): MLR assays comparing untreated and CPS treated iDCs. Description as Figure 3a. Asterisks mark statistically significant difference (*** p < 0.001 and **** p < 0.0001). ns: no statistical significance. (n = 6). (c): MLR assays comparing untreated and BOUND treated iDCs. Description as Figure 3a. Asterisks mark statistically significant difference (**** p < 0.0001). ns: no statistical significance. (n = 3–6). (d): MLR assays comparing untreated and UNBOUND treated iDCs. Description as Figure 3a. Asterisks mark statistically significant difference (**** p < 0.0001). ns: no statistical significance (n = 3–6). (e): MLR assays comparing untreated and EE25 treated iDCs. Description as Figure 3a. ns: no statistical significance.
- (n = 3–6).
- 2.5. Impact of Elderberry Derived Substances Regarding the Cytokine Secretion of Dendritic Cell T Cell Co-Cultures
We analyzed, next, if DCs treated with elderberry fraction modulated cytokine secretion from DC- T cells co-cultures using the culture supernatants derived from MLR assays and analyzing them using the cytometric beads array (CBA). Predictably, iDCs, which are known to be poor T cell stimulators, did not increase the production of the inflammatory cytokine IL-6. In contrast, the elderberry-derived substance EC15 induced a significant IL-6 expression compared with untreated iDCs, and the fractions CPS, BOUND, and UNBOUND produced a stronger response (Figure 4a). Fitting with the phenotypic and T cell stimulatory analyses, EE25 did not induce IL-6 expression.
Similar results were obtained when TNF-α secretion was analyzed (Figure 4b). In this case, EC15 induced a slight but non-significant increase in TNF-α secretion when compared to untreated iDCs. However, fractions CPS, BOUND, and UNBOUND induced a statistically highly significant increased cytokine secretion compared to iDCs. Again, no significant TNF-α secretion was induced when iDCs were treated with EE25.
IL-6
80
normalized to iDC
60
40
20
0
10µg/ml
10µg/ml EE25 10µg/ml
C
10µg/ml CPS 10µg/ml
iD
D
D
C15
N
N
U
U
E
O
- N
- O
B
U
(a)
ns *** ** ** ns
50
normalized to iDC
40
30
20
10
0
10µg/ml CPS 10µg/ml
10µg/ml
10µg/ml EE25 10µg/ml
C
iD
D
D
C15
UN
N
U
E
O
O
B
B
UN
(b)
IFN-
150
normalized to iDC
100
50
0
10µg/ml
10µg/ml EE25 10µg/ml
C
10µg/ml CPS 10µg/ml
iD
D
D
EC15
N
N
U
U
O
- N
- O
B
U
(c)
Figure 4. (a): IL-6 cytokine secretion into the supernatant of MLR derived co-cultures. To investigate the secretion of pro-inflammatory cytokines, generated during the DC-T-cell co-culture in the MLR assays, the supernatant was analyzed using a CBA. Asterisks mark statistically significant difference (* p < 0.05, ** p < 0.01 and *** p < 0.001). ns: no statistical significance. (n = 4–10). (b): TNF-α cytokine secretion into the supernatant of MLR derived co-cultures. Description as Figure 4a. Asterisks mark statistically significant difference (** p < 0.01 and *** p < 0.001). ns: no statistical significance.
Figure 4. (a): IL-6 cytokine secretion into the supernatant of MLR derived co-cultures. To investigate the secretion of pro-inflammatory cytokines, generated during the DC-T-cell co-culture in the MLR assays, the supernatant was analyzed using a CBA. Asterisks mark statistically significant difference (* p < 0.05, ** p < 0.01 and *** p < 0.001). ns: no statistical significance. (n = 4–10). (b): TNF-α cytokine secretion into the supernatant of MLR derived co-cultures. Description as Figure 4a. Asterisks mark statistically significant difference (** p < 0.01 and *** p < 0.001). ns: no statistical significance. (n = 4 10). (c): IFN-γ cytokine secretion into the supernatant of MLR derived co-cultures. Description as Figure 4a. Asterisks mark statistically significant difference (**** p < 0.0001). ns: no statistical significance. (n = 4–10). Each dot represent an independent experiment.
- (n = 4–10). (c): IFN-γ cytokine secretion into the supernatant of MLR derived co-cultures. Description
- as Figure 4a. Asterisks mark statistically significant difference (**** p < 0.0001). ns: no statistical significance. (n = 4–10). Each dot represent an independent experiment.
Similar results were obtained when TNF-α secretion was analyzed (Figure 4b). In this case, EC15 induced a slight but non-significant increase in TNF-α secretion when compared to untreated iDCs. However, fractions CPS, BOUND, and UNBOUND induced a statistically highly significant increased cytokine secretion compared to iDCs. Again, no significant TNF-α secretion was induced when iDCs were treated with EE25.
Finally, we analyzed IFN-γ secretion levels (Figure 4c) and found that the fractions CPS, BOUND, and UNBOUND highly increased IFN-γ secretion levels compared to iDCs. Once again, EE25 did not induce the expression of this cytokine. Thus, these data clearly show that fractions CPS, BOUND as well as UNBOUND and, to a lesser extent, also EC15, strongly induce the expression of inflammatory mediators.
In summary, we conclude, that all the elderberry fractions except EE25 induced a phenotypic DC maturation, induced substantial T cell stimulation, and highly increased pro-inflammatory cytokine levels, which would induce potent immune responses.
Finally, we analyzed IFN-γ secretion levels (Figure 4c) and found that the fractions CPS, BOUND, and UNBOUND highly increased IFN-γ secretion levels compared to iDCs. Once again, EE25 did not induce the expression of this cytokine. Thus, these data clearly show that fractions CPS, BOUND as well as UNBOUND and, to a lesser extent, also EC15 strongly induce the expression of inflammatory mediators.
As previously reported, black elderberry has been and is used extensively in a natural way to fight against coughs, colds, and flu [1]. There is also evidence that black elderberry positively influences the outcome of viral upper respiratory infections; however, the main mode of action is still unclear [2–4]. Two scenarios could be responsible for these reported effects: (i) direct antiviral properties, or (ii) immune-enhancing properties of components present in elderberries. Indeed, some studies reported a direct antiviral mechanism, thereby inhibiting viral replication, while others showed that the elderberry extract exhibits strong immunomodulatory properties [5,8,13–16].
In summary, we conclude, that all the elderberry fractions except EE25 induced a phenotypic DC maturation, induced substantial T cell stimulation, and highly increased pro-inflammatory cytokine levels, which would induce potent immune responses.
As previously reported, black elderberry has been and is used extensively in a natural way to fight against coughs, colds, and flu [1]. There is also evidence that black elderberry positively influences the outcome of viral upper respiratory infections; however, the main mode of action is still unclear [2–4]. Two scenarios could be responsible for these reported effects: (i) direct antiviral properties, or (ii) immune-enhancing properties of components
In this study, we analyzed possible immune-modulatory effects in vitro and the results clearly show that an anthocyanin standardized black elderberry extract (ElderCraft®) containing a bioactive polysaccharide fraction, is a potent immune stimulator.
The elderberry extracts we analyzed included a crude polysaccharide enriched fraction (CPS) isolated from the EC15 extract by ethanol precipitation. This CPS fraction was 12-fold enriched in polysaccharides and the anthocyanin content was reduced to >1%, compared to the original EC15 extract. Using anion exchange chromatography, the CPS fraction could be further separated into UNBOUND and BOUND fractions. The monosaccharide composition of the CPS fraction, which was rich in galacturonic acid as well as rhamnose, galactose, and arabinose, suggests the presence of pectic polysaccharides. After ion exchange, the BOUND fraction revealed a composition similar to pectic components as previously reported by [7]. The UNBOUND fraction contained higher amounts of mannose and galactose, in comparison to the BOUND fraction, which suggests an enrichment of neutral polysaccharides. The substantial amount of galacturonic acid in the unbound fraction strongly indicated that the anion exchange column was overloaded and pectic components were unable to bind. Therefore, the CPS, the BOUND, and the UNBOUND fractions contained pectic polysaccharides.
Our results clearly show that all elderberry samples, except for extract EE25, that is, EC15, CPS, BOUND, and UNBOUND, induced a prominent phenotypic maturation of immature DCs. However, extract EE25 had the highest levels of anthocyanins (>2-fold higher than extract EC15) and the CPS fraction had anthocyanin levels <1% of its parent EC15 extract. This strongly suggests that anthocyanins were not correlated with effectiveness.
The maturation of immature DCs is reflected by the upregulation of the surface molecule CD11c, an important integrin to induce adaptive immune responses [17]. Also, MHC class II molecules were strongly induced by the elderberry extract EC15, and the derived polysaccharide-rich fractions CPS, BOUND, and UNBOUND. Since these molecules present the processed antigenic peptides to the T cell receptor (TCR) expressed by antigenspecific T cells, their presence is an absolute prerequisite to activating virus-specific T cells [11]. Again, EE25 did not induce upregulation of MHC class II molecules.
To potently activate virus-specific T cells, co-stimulatory molecules such as CD80, CD86 as well as CD40 expressed only by mature DCs are absolutely vital to induce potent immune responses. In contrast, immature DCs do not express co-stimulatory molecules and instead of inducing efficient immune responses, they induce tolerogenic mechanisms [9]. Noteworthily, all elderberry fractions, except EE25, induced a statistically highly significant upregulation of these costimulatory molecules. Furthermore, also the expression of the CD83 molecule, a very important immune checkpoint only expressed by mature DCs [11], was highly induced by the elderberry extracts, except by EE25. Thus, these data clearly show that the elderberry extracts EC15, CPS, BOUND and UNBOUND induce the phenotypic maturation of DCs, which is an absolute prerequisite for the induction of potent T cell responses.
The next obvious question was, if these observed phenotypic changes, leading to a strong DC maturation, would also translate into a better T cell stimulation. To assess this, we used the MLR assay. Indeed, all elderberry extracts, with the exception of EE25, induced a statistically highly significant DC-mediated T cell stimulation when compared to immature DCs. The stimulation index was comparable to, for example, LPS or cocktail matured DCs, which we and others use to mature DCs [11,18].
A typical functional property of mature DC-T cells interactions, and characteristic of MLR assays, is the production of pro-inflammatory cytokines. Thus, using CBA we assessed the cytokine secretion into the supernatant, induced by different elderberry extract matured DCs in the co-culture with T cells. Interestingly, especially the extracts CPS, BOUND, and UNBOUND induced a statistically significant expression of the cytokines IL-6, TNF-α as well as IFN-γ. These inflammatory cytokines are mechanistically very important for the induction of potent T-cell-mediated immune responses [19]. Therefore, these data support the hypothesis that the elderberry derived extracts EC15, CPS, BOUND and UNBOUND modulate the immune system, in order to fight against viral infections, as reported, for example, by Ho et al. before [7,8].
These authors described that elderberry-derived pectic polymers not only increase the stimulatory activity of macrophages but also induce a strong and dose-dependent complement fixating activity of these cells [7]. In subsequent work, they suggested that anthocyanins and procyanidins induce complement activation and modulate NO production in macrophages [8]. Based on these data, we hypothesize that polysaccharides, as well as anthocyanins, may contribute to the potent immune-modulatory properties of the elderberry extracts. In addition, Kinoshita et al. reported murine data showing that the oral uptake of elderberry juice induced a dose-dependent stimulatory effect, leading to increased titers of virus-neutralizing antibodies in bronchoalveolar lavage fluids as well
- as in the serum of the treated mice [15]. Since DCs are also important for the activation of B cells and thus for the production of antibodies [20], it is conceivable to speculate that the here reported elderberry extract (EC15), and its fractions, that is, CPS, BOUND and UNBOUND, could also enhance antibody production against, for example, different viruses, in vivo.
- at 5 ◦C in a cold room. The precipitate was collected by successive centrifugations (20 min
- at 10,000× g at 5 ◦C) in a Sorvall RC5C Plus ultrafuge (Fisher Scientific Ltd., Loughborough, UK). The pellets were resuspended in UPW, and samples were taken for total sugar and total anthocyanin tests. The supernatants were combined and retained. The pelleted material was then re-precipitated at 75% (v/v) ethanol using the same procedure. The second
precipitate was resuspended in UPW then dialyzed overnight against an excess of UPW. The crude polysaccharide sample (CPS) was frozen and then freeze-dried. Samples were assessed for anthocyanin content [23] and polysaccharide content using the phenol sulfuric acid method [24].
For ion exchange, 500 mg of the sample was resuspended in 10 mL of 100 mM Tris HCl pH 8.0 and applied to a 100 mL column of DEAE-Sepharose equilibrated in the same buffer. The column was eluted with 2 × 50 mL volumes of Tris buffer to give the unbound fraction then sequentially with 50 mL of 0.25 M NaCl, 0.5 M NaCl then 3 × 50 mL of 1 M NaCl in Tris buffer.
The procedure was repeated eight times and the fractions were precipitated with 75% (v/v) ethanol, resuspended in UPW, and freeze-dried. The bulk of the polysaccharides were recovered in the UNBOUND fraction and in the BOUND fraction 1 (0.25 M NaCl).
- 4.4. Determination of Carbohydrate Composition
- 4.5. Sample Preparations for the Treatment of DCs and MLR Assays
- 4.6. Generation of Human Monocyte-Derived Dendritic Cells
- 4.7. Mixed Lymphocytes Reaction (MLR)
On day 7, the above described and pre-treated human iDCs were analyzed regarding their phenotype and function. On day 7, pre-treated iDCs were inoculated at different ratios with 4 × 105 allogeneic NAF cells, and ultrafiltrated elderberry extract EC15, CPS,
BOUND, UNBOUND, and EE25 were added freshly, at the same concentration as used on day 6. As control, untreated iDC were also co-cultured with 4 × 105 allogeneic NAF cells, without the addition of elderberry-derived substances. Subsequently, cells were cultured further for 72 h in 96-well cell culture plates (Falcon, Fisher Scientific), in a total volume of 200 µL/well and 10 µg/mL of elderberry-derived substances. Three days later, cell-free culture supernatants were collected and analyzed for their cytokine content [26]. To investigate the T cell stimulatory potential of elderberry treated DCs, cells were pulsed with 3H-thymidine (1 µC/well; PerkinElmer, Rodgau, Germany) for 16−20 h, and the allogeneic T cell proliferation was assessed using a Wallac 1420 Victor2 Microplate Reader (PerkinElmer). As a control, NAF cells were treated with DynabeadsTM Human T-Activator CD3/CD28 (Thermo Fisher Scientific, Waltham, MA, USA).
- 4.8. Cytometric Bead Array (CBA)
- 4.9. Flow Cytometric Analyses
- 4.10. Statistical Analyses
For statistical analyses, we worked with GraphPad Prism 8.3, using the ordinary one-way ANOVA (Figures 2 and 4), and the 2 way ANOVA Figure 3. Data presented mean values including the SEM. * p < 0.05; ** p < 0.01; *** p < 0.001; and **** p < 0.0001 were considered statistically significant.
Supplementary Materials: The following supporting information can be downloaded at: https: //www.mdpi.com/article/10.3390/ijms23073949/s1.
Author Contributions: L.S., G.M., C.A., S.P. and A.S. designed experiments, analyzed and interpreted the data. L.S., S.P. and A.S. wrote the manuscript. S.P. provided black elderberry extracts. All authors have read and agreed to the published version of the manuscript.
Funding: This work was supported by the Deutsche Forschungsgemeinschaft (DFG) via the SFB1181 project B03 and STE432/15-1 (to AS).
Institutional Review Board Statement: The study was conducted in accordance with the Declaration of Helsinki, and approved by the Ethics Committee of the University Hospital Erlangen (protocol code 357_19B, date of approval 11 October 2019), for studies involving humans.
Informed Consent Statement: Informed consent was obtained from all subjects involved in the study. Data Availability Statement: All data have been presented within the manuscript. Conflicts of Interest: S.P. is employed at IPRONA AG/SPA. All the other authors do not have any potential competing interest.
Figures
Used In Evidence Reviews
Similar Papers
The Journal of international medical research · 2004
Randomized study of the efficacy and safety of oral elderberry extract in the treatment of influenza A and B virus infections.
Phytochemistry · 2009
Elderberry flavonoids bind to and prevent H1N1 infection in vitro.
Journal of alternative and complementary medicine (New York, N.Y.) · 1995
Inhibition of several strains of influenza virus in vitro and reduction of symptoms by an elderberry extract (Sambucus nigra L.) during an outbreak of influenza B Panama.
Alternative medicine review : a journal of clinical therapeutic · 2007
Colds and influenza: a review of diagnosis and conventional, botanical, and nutritional considerations.
BMC complementary and alternative medicine · 2011
Inhibitory activity of a standardized elderberry liquid extract against clinically-relevant human respiratory bacterial pathogens and influenza A and B viruses.
Complementary therapies in medicine · 2019